Emerging Technologies towards HIV/AIDS

Emerging infectious diseases represent a grave threat to animal and human populations in terms of their impact on global health, agriculture and the economy. HIV Vaccines developed for emerging infections in animals can protect animal health and prevent transmission of zoonotic diseases to humans. The HIV vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations towards HIV/AIDS.

  • Nanotechnology
  • Stemcell Engineering

Related Conference of Emerging Technologies towards HIV/AIDS

October 19-20, 2018

10th World Congress and Expo on Immunology

New York, USA
October 29-30, 2018

6th International Conference on HIV/AIDS, STDs and STIs

San Francisco, USA
November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland (Louis Fitzgerald Hotel)
December 05-06, 2018

Global Meet on Immunology, Hematology and Molecular Biology

Portugal, Lisbon
December 06-08, 2018

Annual Congress on Antibiotics and Antimicrobial Resistance

Amsterdam, Netherlands
March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
November 22-23, 2019 |

World Conference on Vaccine and Immunology

Dubai, UAE

Emerging Technologies towards HIV/AIDS Conference Speakers

Recommended Sessions

Related Journals

Are you interested in